Advances in Multiple Myeloma
(2017)
Advances in Multiple Myeloma: pp.
-.
Chapter 14
Rationale and Design of the German-Speaking Myeloma Multicenter Group (GMMG) Trial ReLApsE: A Randomized, Open, Multicenter Phase III Trial of Lenalidomide/Dexamethasone versus Lenalidomide/Dexamethasone plus Subsequent Autologous Stem Cell Transplantation and Lenalidomide Maintenance in Patients with Relapsed Multiple Myeloma